[Clinical dosimetry and long-term therapeutic results in Cushing's disease].
D000293:Adolescent; D000328:Adult; D001247:Asthenia; D002986:Clinical Trials as Topic; D003480:Cushing Syndrome / Q000532:radiotherapy*; D005260:Female; D005500:Follow-Up Studies; D006049:Gold Isotopes / Q000627:therapeutic use; D006801:Humans; D006983:Hypertrichosis; D007030:Hypothalamo-Hypophyseal System / Q000528:radiation effects; D008297:Male; D008875:Middle Aged; D009133:Muscular Atrophy; D011379:Prognosis; D011879:Radiotherapy Dosage; D013238:Stereotaxic Techniques; D014581:Urticaria; D015020:Yttrium Isotopes / Q000627:therapeutic use
D006049:Gold Isotopes; D015020:Yttrium Isotopes
Dosimétrie clinique et résultats thérapeutiques éloignés dans la maladie de Cushing.